POLYCLONAL HUMAN PLACENTAL LACTOGEN(HPL)

General description

Human placental lactogen (hPL), also previously known as "human chorionic somatomammotropin", is a 22 kD protein with partial homology to growth hormone. hPL is first detectable in the maternal serum in the fifth week of gestation and reaches a plateau by the thirty-fourth week. hPL has been demonstrated by immunochemistry in the syncytiotrophoblastic cells of choriocarcinoma. A rare variant of trophoblastic tumor has been reported in the testis with resemblance to uterine placental site trophoblastic tumor. It consists purely of intermediate trophoblasts which are diffusely positive for hPL and focally for ß-hCG.

Legal Information

Cell Marque is a trademark of Sigma-Aldrich Co. LLC

Linkage

Human Placental Lactogen (hPL) Positive Control Slides, Product No. 266S, are available for immunohistochemistry (formalin-fixed, paraffin-embedded sections).

Other Notes

For Technical Service please contact: 800-665-7284 or email: [email protected]

Physical form

Solution in Tris Buffer, pH 7.3-7.7, with 1% BSA and ﹤0.1% Sodium Azide

Preparation Note

Download the IFU specific to your product lot and formatNote: This requires a keycode which can be found on your packaging or product label.

Quality